4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-054540
Chairman and CEO bought 9,701 shares at an average $1.55 ($15,022)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-08-31 | Purchase | +7,201 | $1.55 | $11,162 | 10,865,065 | D |
| Niihara Yutaka Chairman and CEO | 2021-09-01 | Purchase | +1,500 | $1.54 | $2,310 | 10,866,565 | D |
| Niihara Yutaka Chairman and CEO | 2021-09-02 | Purchase | +1,000 | $1.55 | $1,550 | 10,867,565 | D |
| Open-market purchases · 9,701 sh · avg $1.55 · $15,022 | |||||||
Loading xslF345X03/doc4.xml…